Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

August 20, 2014

By Larry Husten

Edited by Lorenzo Di Francesco, MD, FACP, FHM

Acute use of the popular macrolide antibiotic clarithromycin has been linked to a small but significant increase in cardiac death, according to a BMJ study.

Using Danish registries, researchers analyzed the effects …

By Amy Orciari Herman

Edited by Lorenzo Di Francesco, MD, FACP, FHM

An intervention that combines free smoking cessation medication with automated telephone calls can help smokers quit after hospital discharge, a JAMA study finds.

Some 400 hospitalized smokers who wanted …

By Kelly Young

Edited by Lorenzo Di Francesco, MD, FACP, FHM

Pulse oximetry should not be the sole factor in deciding whether to admit an infant presenting with bronchiolitis, the authors of a JAMA study suggest. …

By Larry Husten

Edited by Lorenzo Di Francesco, MD, FACP, FHM

An analysis in the Journal of the American College of Cardiology adds to the debate around recent guidelines that recommend raising the therapeutic target for systolic blood pressure in patients aged 60 and older, from 140 mm Hg to 150 mm Hg.

Researchers performed …

August 19, 2014

By Kelly Young

Edited by Jaye Elizabeth Hefner, MD

Two studies in JAMA Internal Medicine delve into the topic of overscreening older adults for cancer.

In the first, researchers calculated 9-year mortality risk for roughly 27,000 people aged 65 and older who completed the National Health Interview Survey. For participants with …

By Kelly Young

Edited by Jaye Elizabeth Hefner, MD

Survival among patients with cystic fibrosis significantly improved between 2000 and 2010, according to a study in the Annals of Internal Medicine.

Researchers studied a cohort of roughly …

By Amy Orciari Herman

Edited by Jaye Elizabeth Hefner, MD

Older adults who begin taking atypical antipsychotics face increased risk for acute kidney injury in the first few months of use, according to a retrospective study in the Annals of Internal Medicine.

Using Canadian …

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: A …

August 18, 2014

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The FDA has approved bevacizumab (Avastin) for metastatic, persistent, or recurrent cervical cancer to be used in combination with …

Pages